MENU
BTAI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioXcel Therapeutics (BTAI) Earnings Date & Reports

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

BTAI is expected to report earnings to rise 97.96% to -97 cents per share on November 18

BioXcel Therapeutics BTAI Stock Earnings Reports
Q3'26
Est.
$-0.97
Q2'26
Missed
by $0.07
Q1'26
Beat
by $2.49
Q4'25
Missed
by $0.49
Q3'25
Missed
by $2.09
The last earnings report on August 27 showed earnings per share of -49 cents, missing the estimate of -42 cents. With 29.22M shares outstanding, the current market capitalization sits at 22.52M.
View a ticker or compare two or three
BTAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Biotechnology
Address
555 Long Wharf Drive
Phone
+1 475 238-6837
Employees
29
Web
https://www.bioxceltherapeutics.com